These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29915533)

  • 21. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-Genome DNA Methylation Analysis of Peripheral Blood Mononuclear Cells in Multiple Sclerosis Patients with Different Disease Courses.
    Kulakova OG; Kabilov MR; Danilova LV; Popova EV; Baturina OA; Tsareva EY; Baulina NM; Kiselev IS; Boyko AN; Favorov AV; Favorova OO; Vlassov VV
    Acta Naturae; 2016; 8(3):103-110. PubMed ID: 27795849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
    Montalban X; Sastre-Garriga J; Filippi M; Khaleeli Z; Téllez N; Vellinga MM; Tur C; Brochet B; Barkhof F; Rovaris M; Miller DH; Polman CH; Rovira A; Thompson AJ
    Mult Scler; 2009 Dec; 15(12):1459-65. PubMed ID: 19995843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.
    Kantarci OH; Lebrun C; Siva A; Keegan MB; Azevedo CJ; Inglese M; Tintoré M; Newton BD; Durand-Dubief F; Amato MP; De Stefano N; Sormani MP; Pelletier D; Okuda DT
    Ann Neurol; 2016 Feb; 79(2):288-94. PubMed ID: 26599831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis.
    McDonnell GV; Mawhinney H; Graham CA; Hawkins SA; Middleton D
    J Neurol Sci; 1999 May; 165(1):77-83. PubMed ID: 10426152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics of primary progressive multiple sclerosis.
    Cree BA
    Handb Clin Neurol; 2014; 122():211-30. PubMed ID: 24507520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease.
    Stoessel D; Schulte C; Teixeira Dos Santos MC; Scheller D; Rebollo-Mesa I; Deuschle C; Walther D; Schauer N; Berg D; Nogueira da Costa A; Maetzler W
    Front Aging Neurosci; 2018; 10():51. PubMed ID: 29556190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different cognitive profiles of Brazilian patients with relapsing-remitting and primary progressive multiple sclerosis.
    Rodrigues DN; Paes RA; Vasconcelos CC; Landeira-Fernandez J; Alvarenga MP
    Arq Neuropsiquiatr; 2011 Aug; 69(4):590-5. PubMed ID: 21877025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
    PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
    Malhotra S; Fissolo N; Tintoré M; Wing AC; Castilló J; Vidal-Jordana A; Montalban X; Comabella M
    J Neuroinflammation; 2015 Mar; 12():48. PubMed ID: 25879961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-Platform Characterization of Cerebrospinal Fluid and Serum Metabolome of Patients Affected by Relapsing-Remitting and Primary Progressive Multiple Sclerosis.
    Murgia F; Lorefice L; Poddighe S; Fenu G; Secci MA; Marrosu MG; Cocco E; Atzori L
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32245176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin generation correlates with disease duration in multiple sclerosis (MS): Novel insights into the MS-associated prothrombotic state.
    Parsons ME; O'Connell K; Allen S; Egan K; Szklanna PB; McGuigan C; Ní Áinle F; Maguire PB
    Mult Scler J Exp Transl Clin; 2017; 3(4):2055217317747624. PubMed ID: 29318029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Employment and absenteeism in working-age persons with multiple sclerosis.
    Salter A; Thomas N; Tyry T; Cutter G; Marrie RA
    J Med Econ; 2017 May; 20(5):493-502. PubMed ID: 28035846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon beta for primary progressive multiple sclerosis.
    Rojas JI; Romano M; Ciapponi A; Patrucco L; Cristiano E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006643. PubMed ID: 19160292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon Beta for primary progressive multiple sclerosis.
    Rojas JI; Romano M; Ciapponi A; Patrucco L; Cristiano E
    Cochrane Database Syst Rev; 2010 Jan; (1):CD006643. PubMed ID: 20091602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of IFN-β inducible gene expression in primary-progressive and relapsing-remitting multiple sclerosis.
    Boppana S; Mindur JE; Balashov KE; Dhib-Jalbut S; Ito K
    J Neuroimmunol; 2013 Dec; 265(1-2):68-74. PubMed ID: 24200257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis.
    Gil-Perotin S; Castillo-Villalba J; Cubas-Nuñez L; Gasque R; Hervas D; Gomez-Mateu J; Alcala C; Perez-Miralles F; Gascon F; Dominguez JA; Casanova B
    Front Neurol; 2019; 10():1008. PubMed ID: 31608004
    [No Abstract]   [Full Text] [Related]  

  • 38. Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.
    Sumelahti ML; Tienari PJ; Hakama M; Wikström J
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):25-8. PubMed ID: 12486261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of primary progressive multiple sclerosis.
    Ebers GC
    Mult Scler; 2004 Jun; 10 Suppl 1():S8-13; discussion S13-5. PubMed ID: 15218804
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.